ADENIUM BIOTECH ApS: Financial statements 2012
CVR: 33882785
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ADENIUM BIOTECH ApS (CVR 33882785) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -11,533,772 and a net result of DKK -9,560,530. Equity in the 2012 report amounted to DKK 9,962,704. The solvency ratio was 93.4%.
- Gross Profit
- DKK -11,533,772
- Profit/Loss
- DKK -9,560,530
- Equity
- DKK 9,962,704
- Total Assets
- DKK 10,670,603
Official annual report
Keep an eye on ADENIUM BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of June 7, 2012, Andreas Rutger Segerros has joined the board of directors of ADENIUM BIOTECH ApS.
As of June 7, 2012, Stephan Christgau has joined the board of directors of ADENIUM BIOTECH ApS.
As of June 7, 2012, Khalid Islam is registered as chairman of ADENIUM BIOTECH ApS.
As of January 16, 2012, JUT NR. 2180 A/S has been appointed auditor of ADENIUM BIOTECH ApS.
About ADENIUM BIOTECH ApS
ADENIUM BIOTECH ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2011. The company has been dissolved on 4 January 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -2,898,094 and a net result of DKK -3,504,941 compared with DKK -4,602,176 the year before. Equity in the 2019 report amounted to DKK -1,576,302.